[1]
Sanjay Kalra, AG Unnikrishnan, Arundhati Dasgupta, Atul Dhingra, Ganapathi Bantaval, Manash P Baruah, Mathew John, Rakesh Sahay, Saptarshi Bhattacharya and Bharath HS 2022. The Expanding Role of Dapagliflozin Beyond the Glucose-lowering Effec. Indian Journal Of Clinical Practice. 33, 3 (Aug. 2022), 21–28.